Literature DB >> 8050170

Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency.

P Aukrust1, F Müller, S S Frøland.   

Abstract

Monocyte and macrophage dysfunction may be important for both immunopathogenesis and clinical manifestations in subgroups of patients with primary hypogammaglobulinaemia. In the present study we examined the ability to generate reactive oxygen species (ROS) in isolated monocytes from these patients by two different methods: superoxide dismutase (SOD) inhibitable cytochrome c reduction by O2- and nitroblue tetrazolium (NBT) reduction. Monocyte from patients with common variable immunodeficiency (CVI) demonstrated significantly enhanced ROS generation both unstimulated and stimulated (unopsonized zymosan and phorbol myristate acetate (PMA)). The enhanced oxidative burst response in CVI patients was found both with and without serum containing medium. Furthermore, serum from CVI patients did significantly enhance the oxidative burst response in monocytes from healthy blood donors compared with the effect of control serum. The enhanced ROS generation in CVI patients was significantly correlated with elevated serum levels of neopterin, reduced numbers of CD4+ lymphocytes in peripheral blood and occurrence of splenomegaly. In contrast to the CVI group, monocytes from patients with X-linked agammaglobulinaemia (XLA) did not show enhanced ROS generation. The increased oxidative burst response in monocytes from CVI patients most probably reflects in vivo activation of these cells. Our observations indicate the presence of a subgroup of CVI patients characterized by chronic immune activation particularly of monocytes. The enhanced ROS generation might be involved in immunopathogenesis (e.g. T cell dysfunction) and in the pathogenesis of clinical manifestations (e.g. malignancies and autoimmune disorders) in these patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050170      PMCID: PMC1534688          DOI: 10.1111/j.1365-2249.1994.tb06073.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

Review 1.  Lymphocyte surface phenotype in common variable immunodeficiency.

Authors:  G P Spickett; N Matamoros; J Farrant
Journal:  Dis Markers       Date:  1992 Mar-Apr       Impact factor: 3.434

2.  The microestimation of succinate and the extinction coefficient of cytochrome c.

Authors:  V MASSEY
Journal:  Biochim Biophys Acta       Date:  1959-07

Review 3.  Free radicals, antioxidants, and human disease: where are we now?

Authors:  B Halliwell; J M Gutteridge; C E Cross
Journal:  J Lab Clin Med       Date:  1992-06

Review 4.  Oxidative stress as a mediator of apoptosis.

Authors:  T M Buttke; P A Sandstrom
Journal:  Immunol Today       Date:  1994-01

5.  A rapid densitometric microassay for nitroblue tetrazolium reduction and application of the microassay to macrophages.

Authors:  E Pick; J Charon; D Mizel
Journal:  J Reticuloendothel Soc       Date:  1981-12

6.  Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features.

Authors:  P Aukrust; S S Frøland; F Müller
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

7.  Zymosan-induced tyrosine phosphorylations in human monocytes. Role of protein kinase C.

Authors:  M V Sanguedolce; C Capo; M Bouhamdan; P Bongrand; C K Huang; J L Mege
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

8.  Cultured human monocytes require exposure to bacterial products to maintain an optimal oxygen radical response.

Authors:  M J Pabst; H B Hedegaard; R B Johnston
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

9.  Rapid priming of human monocytes by human hematopoietic growth factors: granulocyte-macrophage colony-stimulating factor (CSF), macrophage-CSF, and interleukin-3 selectively enhance superoxide release triggered by receptor-mediated agonists.

Authors:  A Yuo; S Kitagawa; K Motoyoshi; E Azuma; M Saito; F Takaku
Journal:  Blood       Date:  1992-03-15       Impact factor: 22.113

10.  Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes.

Authors:  P Aukrust; F Müller; S S Frøland
Journal:  Clin Immunol Immunopathol       Date:  1994-03
View more
  12 in total

Review 1.  Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID).

Authors:  L Hammarström; I Vorechovsky; D Webster
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 2.  Therapeutic strategies in common variable immunodeficiency.

Authors:  W A Carrock Sewell; Matthew Buckland; Stephen R A Jolles
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Defective functions of polymorphonuclear neutrophils in patients with common variable immunodeficiency.

Authors:  Sarah Casulli; Hélène Coignard-Biehler; Karima Amazzough; Michka Shoai-Tehrani; Jagadeesh Bayry; Nizar Mahlaoui; Carole Elbim; Srini V Kaveri
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

Review 4.  Autoimmunity and Inflammation in CVID: a Possible Crosstalk between Immune Activation, Gut Microbiota, and Epigenetic Modifications.

Authors:  Silje F Jørgensen; Børre Fevang; Pål Aukrust
Journal:  J Clin Immunol       Date:  2018-11-21       Impact factor: 8.317

5.  Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation.

Authors:  S F Jørgensen; M Trøseid; M Kummen; J A Anmarkrud; A E Michelsen; L T Osnes; K Holm; M L Høivik; A Rashidi; C P Dahl; M Vesterhus; B Halvorsen; T E Mollnes; R K Berge; B Moum; K E A Lundin; B Fevang; T Ueland; T H Karlsen; P Aukrust; J R Hov
Journal:  Mucosal Immunol       Date:  2016-03-16       Impact factor: 7.313

6.  Antioxidative capacity in patients with common variable immunodeficiency.

Authors:  J Reichenbach; R Schubert; C Schwan; K Müller; H J Böhles; S Zielen
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

7.  Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct.

Authors:  Brian C Schanen; Ajay S Karakoti; Sudipta Seal; Donald R Drake; William L Warren; William T Self
Journal:  ACS Nano       Date:  2009-09-22       Impact factor: 15.881

8.  Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation.

Authors:  B Fevang; A Yndestad; J K Damås; B Halvorsen; A M Holm; K Beiske; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2009-08-12       Impact factor: 4.330

Review 9.  Persistent Immune Activation in CVID and the Role of IVIg in Its Suppression.

Authors:  Dominic Paquin-Proulx; Johan K Sandberg
Journal:  Front Immunol       Date:  2014-12-16       Impact factor: 7.561

10.  NADPH oxidase mediates the oxygen-glucose deprivation/reperfusion-induced increase in the tyrosine phosphorylation of the N-methyl-D-aspartate receptor NR2A subunit in retinoic acid differentiated SH-SY5Y Cells.

Authors:  Phillip H Beske; Darrell A Jackson
Journal:  J Mol Signal       Date:  2012-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.